Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RICHARD D SHELL

Allopathic & Osteopathic Physicians Pediatrics Pediatric Pulmonology

NPI
1497741110
CMS profile
719197
Location
COLUMBUS, OH

General Payments · PY2019–2023

$40,803.46

  • Reported across 93 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$7,365.85

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
AveXis $4,665.85 14
PFIZER INC. $2,700.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $8,665.37 31
PY2020 $9,552.52 24
PY2021 $2,501.75 3
PY2022 $12,717.97 20
PY2023 $7,365.85 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 2019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $45.45 03/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916061 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $71.43 03/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916063 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $105.20 03/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916065 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $81.82 03/09/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916067 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $2,909.09 03/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916069 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $128.57 03/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916071 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $81.82 04/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916073 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $80.00 04/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916075 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $108.36 06/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916077 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $428.57 06/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916079 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $81.82 06/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916081 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $128.57 06/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916083 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $81.82 06/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916085 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $333.33 10/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016916087 CMS
PFIZER INC. $2,700.00 12/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1050519919 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.